Medbio07.23.18
Medbio has announced the beginning of a new partnership. Effective July, 18, 2018, Graham Partners, a private equity firm based in Philadelphia, Pa., has made a substantial investment in Medbio. According to Medbio, this new partnership will allow the company to meet its very strong growth objectives, and ensure it continues to build momentum as it expands within the medical device and biotechnology industries. In a company statement, Medbio explained the investment enables the company to offer customers additional technologies and capabilities, and expand facilities and footprint.
Graham brings strong industry and operational resources that will help Medbio achieve growth initiatives. According to the statement, the arrangement will be transparent to customers. Chris Williams remains as Medbio’s president and CEO.
Graham brings strong industry and operational resources that will help Medbio achieve growth initiatives. According to the statement, the arrangement will be transparent to customers. Chris Williams remains as Medbio’s president and CEO.